• Profile
Close

Analysis of 153,115 patients with hematological malignancies refines the spectrum of familial risk

Blood Aug 14, 2019

Sud A, Chattopadhyay S, Thomsen H, et al. - Using the Swedish Family-Cancer Database, researchers analyzed data on over 16 million individuals to determine the familial risk of the various hematological malignancies as well as their possible inter-relationship. Overall 153,115 patients who received a diagnosis of a primary hematological malignancy were identified. In 391,131 first-degree relatives of these patients, standardized incident ratios were calculated to quantify familial relative risks (FRRs). For the same tumor type, increased FRRs were displayed by most of the hematological malignancies. For mixed cellularity Hodgkin lymphoma, lymphoplasmacytic lymphoma and mantle cell lymphoma, the highest FRRs were noted. Also, pleiotropic links were evident, notably an increased familial risk of other B-cell tumors and myeloproliferative neoplasms was found in relation to chronic lymphocytic leukemia. As per the evidence generated in this study, many hematological malignancies had shared etiological factors. For the detection of people at increased risk and for informing future gene discovery initiatives, information was generated in this inquiry.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay